Skip to main content
HR 2796 104th Congress House Health Artificial implants Blood Chemicals Civil Rights and Liberties, Minority Issues Commerce Defective products Discrimination in medical care Donation of organs, tissues, etc. Economics and Public Finance Environmental Protection Federal aid to health facilities Government Operations and Politics Government paperwork Hospital care Informed consent (Medical law) Law Licenses Mammography Medical ethics

Breast Implant Accountability Act

Introduced: December 15, 1995 See on congress.gov
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 18, 1995
Referred to the Subcommittee on Health and Environment.
Dec 15, 1995
Referred to the House Committee on Commerce.
Dec 15, 1995
Introduced in House
 Plain-English summary Congressional Research Service

Breast Implant Accountability Act - Requires each manufacturer of a breast implant to notify each individual with a silicone gel or saline implant implanted before 1994 that the manufacturer will pay for removal and will allow the recipient to select the physician and hospital or center for the removal.

Directs the Secretary of Health and Human Services to conduct or contract for research on the physiological, neurological, and immunological effects of chemicals found in, or used in the manufacture of, breast implants.

Prohibits: (1) physicians from doing silicone breast implants without patient execution of a consent form prescribed by the Secretary and from refusing the treatment of a patient because the patient has received a breast implant; (2) grants to an organ procurement organization if the organization has allowed an individual who has a breast implant to donate an organ; and (3) licensing of any blood collection entity if the entity receives blood from such an individual.

What's happening now December 18, 1995

Referred to the Subcommittee on Health and Environment.

 Committees of jurisdiction 2